What is BBNX's non us — revenue?

BBNX (BBNX) reported non us — revenue of $0 in Q1 2026.

What does non us — revenue mean?

This metric represents the total revenue generated from sales of medical devices and related services within geographic regions outside of the company's primary domestic market. It serves as a key indicator of the company's international commercial expansion and the global adoption rate of its adaptive closed-loop insulin delivery technology. Tracking this figure helps investors assess the company's ability to navigate regulatory environments and compete in diverse international healthcare markets.

BBNX BBNX Non Us — Revenue

Similar metrics at other companies

TMDXNon Us — Revenue

$5.65M+38.9%

ATECNon Us — Revenue (Gross)

$11.75M+16.7%

ACLSNon Us — Revenue

$175.5M-19.7%

NSSCNon Us — Revenue

$819K+71.0%

AHRNon Us — Revenue

$1.67M+7.3%

SPRYNon Us — Revenue

$2.45M—

Other financials

Income statement

See full

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

See full

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

See full

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

See full

Market cap$708.98M-8.6%

Enterprise value$685.68M—

P/S6.4×—

Profitability

See full

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

See full

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's non us — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BBNX's non us — revenue?: BBNX (BBNX) reported non us — revenue of $0 in Q1 2026.
What does non us — revenue mean?: This metric represents the total revenue generated from sales of medical devices and related services within geographic regions outside of the company's primary domestic market. It serves as a key indicator of the company's international commercial expansion and the global adoption rate of its adaptive closed-loop insulin delivery technology. Tracking this figure helps investors assess the company's ability to navigate regulatory environments and compete in diverse international healthcare markets.